0001209191-23-023385.txt : 20230405
0001209191-23-023385.hdr.sgml : 20230405
20230405171009
ACCESSION NUMBER: 0001209191-23-023385
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230403
FILED AS OF DATE: 20230405
DATE AS OF CHANGE: 20230405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Collard Craig A
CENTRAL INDEX KEY: 0001363558
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33221
FILM NUMBER: 23803419
BUSINESS ADDRESS:
BUSINESS PHONE: 919-678-6611
MAIL ADDRESS:
STREET 1: C/O CORNERSTONE THERAPEUTICS INC.
STREET 2: 1255 CRESCENT GREEN DRIVE, SUITE 250
CITY: CARY
STATE: NC
ZIP: 27518
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/
CENTRAL INDEX KEY: 0000818033
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 942875566
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582514400
MAIL ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: AP PHARMA INC /DE/
DATE OF NAME CHANGE: 20010511
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-03
0
0000818033
HERON THERAPEUTICS, INC. /DE/
HRTX
0001363558
Collard Craig A
4242 CAMPUS POINT COURT, SUITE 200
SAN DIEGO
CA
92121
1
1
0
0
Chief Executive Officer
0
Employee Stock Option (Right to Buy)
1.78
2023-04-03
4
A
0
3000000
0.00
A
2033-04-03
Common Stock
3000000
3000000
D
Restricted Stock Units
0.00
2023-04-03
4
A
0
250000
0.00
A
Common Stock
250000
250000
D
Employee Performance Stock Option (Right to Buy)
1.78
2023-04-03
4
A
0
4250000
0.00
A
2033-04-03
Common Stock
4250000
4250000
D
The stock option vests and becomes exercisable with respect to 750,000 shares on the first anniversary of the date of grant, followed by 2,250,000 shares vesting ratably each month over the subsequent three years, such that 3,000,000 options will be fully vested on the four-year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date.
The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date.
The stock option vests and becomes exercisable with respect to escalating portions of the option grant upon the Issuer's stock price reaching certain pre-established levels ranging from $4.50 to $9.00 per share, subject to the Reporting Person's continued service to the Issuer through the vesting date.
/s/ Lisa Peraza Attorney-in-fact for Craig A. Collard
2023-04-05